Blog

It is with great sadness that we offer condolences on the sudden passing of Dr. Andrew Hruszkewycz of the National Cancer Institute (NCI) on December 16th. Andrew was a friend and colleague to many at PCF, dedicated to the work of finding a cure for cancer, and he will be deeply missed.

Dr. Hruszkewycz attended the Case Western Reserve University School of Medicine where he received both his MD/PhD degrees and then completed his pathology residency at Temple University and George Washington University Hospitals.  He served as a Senior Staff Fellow in the Department of Laboratory Medicine at the NIH Clinical Center.  His cancer research included investigations in the areas of oxidative stress, chemical carcinogenesis, molecular diagnostics, and translational cancer research in urologic cancers.  Dr. Hruszkewycz served as a Scientist Associate at the NCI Frederick Cancer Research and Development Center, Special Expert with the Prostate and Urologic Cancer Research Group of the NCI Division of Cancer Prevention, and was a Program Director with the Translational Research Program of the NCI Division of Cancer Treatment and Diagnosis.

He was highly respected and well-liked member of the SPORE (Specialized Programs of Research Excellence) family, working in the bladder and urological cancer specialties.  Dr. Howard Soule, EVP and Chief Science Officer of PCF, reflected, “Dr. Andrew Hruszkewycz was more than a colleague – he was my friend. For over a decade, my relationship with him, I am certain, moved the cancer field forward with the patients he cared for so much at the forefront. Rest in peace, my friend – you are missed.” Dr. Hruszkewycz will be missed by people here, and our thoughts and prayers go out to his family.